Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Real World Evidence: ‘Hot Topic’ At US FDA, But Not On Front Burner

Executive Summary

Officials are enthusiastic about the possibility of ‘real world evidence’ supporting the regulatory process – but are also eager to tamp down expectations (or fears) that it will make a big difference any time soon.

Advertisement

Related Content

Real World Evidence Is Critical To Pharma’s Future: Can We Agree On What It Is?
J.P. Morgan Notebook Day 1: PCSK9 Face-Off, Teva’s Slowed Growth, Merck’s Keytruda Wins, Lilly’s CDK4/6 Hopes And More
J.P. Morgan Notebook Day 1: PCSK9 Face-Off, Teva’s Slowed Growth, Merck’s Keytruda Wins, Lilly’s CDK4/6 Hopes And More
Califf Sets Exit At FDA, Ostroff Could Return To Acting Commissioner Post
US FDA Might Be Temporarily Headed By Ostroff As Califf Sets His Departure
Oncology Drug Development: Would A New Pricing Model Help?
FDA’s Tough Stance On Patient-Reported Outcomes Underscored At Repros Meeting
Hypogonadism Trial Designs: FDA Panel Favors Symptom Assessments, Fertility Measures
FDA/CMS Collaboration: “Sleeper Group” Goes Public With Call For Real-World Evidence

Topics

Advertisement
UsernamePublicRestriction

Register

PS119687

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel